LDL-C Goal Attainment With Ezetimibe Plus Simvastatin Coadministration vs Atorvastatin or Simvastatin Monotherapy in Patients at High Risk of CHD

ABSTRACT: AIMS: To compare the proportion of patients at high risk for coronary heart disease (CHD) achieving the recommended low-density lipoprotein cholesterol (LDL-C) treatment goal of < 100 mg/dL and the optional LDL-C target of < 70 mg/dL with coadministration of ezetimibe and simvastatin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: McKenney, James, Ballantyne, Christie M., Feldman, Theodore A., Brady, William E., Shah, Arvind, Davies, Michael J., Palmisano, Joanne, Mitchel, Yale B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Medscape 2005
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1681670/
https://ncbi.nlm.nih.gov/pubmed/16369229
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak